The lung functioning of pulmonary hypertension patients treated with Bayer’s Adempas improved by 50 percent over a median…
Articles by Ana Pamplona, PhD
A subcutaneous infusion of Remodulin (treprostinil) was an effective and tolerable treatment against severe pulmonary hypertension associated with chronic kidney disease…
A new study identifies the hemodynamic variables that distinguish patients with idiopathic pulmonary arterial hypertension (PAH) from those with isolated…
During the American College of Cardiology (ACC) Congress held this March (14-16) in San Diego, data from the pivotal Selexipag (Uptravi®) Phase III …
Courtesy of EchoSense A recent review on imaging of pulmonary vascular disease and the right ventricle by…
A new study highlighting a diagnostic test based on peripheral blood for idiopathic pulmonary fibrosis entitled “…
A new study on pulmonary arterial hypertension (PAH) entitled “Echocardiographic Assessment of Estimated Right Atrial Pressure…
New research is shedding light on the progression of CTEPH. A novel study on chronic thromboembolic pulmonary hypertension (CTEPH), entitled…
A recent study, entitled “The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension,”…
A new study, entitled “Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis,” conducted at…
A new study, entitled “The Sphingosine Kinase 1 / Sphingosine-1-Phosphate Pathway in Pulmonary Arterial Hypertension” conducted…
Omentin, an adipocyte-derived cytokine, is a potential novel candidate to treat obesity-related cardiovascular disease. Dr. Kyosuke Kazama and colleagues from…